Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT03834753

Public ClinicalTrials.gov record NCT03834753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Effectiveness, Multicenter, Randomized, Double-masked, Controlled Study of the Efficacy and Safety of ONS-5010 in Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Study identification

NCT ID
NCT03834753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Outlook Therapeutics, Inc.
Industry
Enrollment
228 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2019 (Actual)
Primary completion
Jun 7, 2021 (Actual)
Completion
Jul 8, 2021 (Actual)
Last update posted
Aug 3, 2026

2019 – 2021

United States locations

U.S. sites
50
U.S. states
21
U.S. cities
49
Facility City State ZIP Site status
Clinical Site Tucson Arizona 85710 —
Clinical Site Arcadia California 91007 —
Clinical Site Beverly Hills California 90211 —
Clinical Site Campbell California 95008 —
Clinical Site Glendale California 91203 —
Clinical Site Laguna Hills California 92653 —
Clinical Site Long Beach California 90807 —
Clinical Site Mountain View California 94040 —
Clinical Site Oxnard California 93036 —
Clinical Site Palm Desert California 92260 —
Clinical Site Poway California 92064 —
Clinical Site Sacramento California 95841 —
Clinical Site Santa Maria California 93454 —
Clinical Site Tustin California 92780 —
Clinical Site Golden Colorado 80401 —
Clinical Site Hamden Connecticut 06518 —
Clinical Site Clearwater Florida 33761 —
Clinical Site Pinellas Park Florida 33782 —
Clinical Site Sarasota Florida 24233 —
Clinical Site Winter Haven Florida 33880 —
Clinical Site Augusta Georgia 30909 —
Clinical Site Marietta Georgia 30060 —
Clinical Site Downers Grove Illinois 60615 —
Clinical Site Lemont Illinois 60439 —
Clinical Site Springfield Illinois 62704 —
Clinical Site Indianapolis Indiana 46290 —
Clinical Site Hagerstown Maryland 21740 —
Clinical Site Edina Minnesota 55435 —
Clinical Site St Louis Missouri 63144 —
Clinical Site Bloomfield New Jersey 07003 —
Clinical Site Albuquerque New Mexico 87109 —
Clinical Site New York New York 10021 —
Clinical Site Chambersburg Pennsylvania 17201 —
Clinical Site Monroeville Pennsylvania 15146 —
Clinical Site Rapid City South Dakota 57701 —
Clinical Site Germantown Tennessee 38138 —
Clinical Site Abilene Texas 79606 —
Clinical Site Amarillo Texas 79106 —
Clinical Site Arlington Texas 76012 —
Clinical Site Dallas Texas 75231 —
Clinical Site Grapevine Texas 76051 —
Clinical Site Houston Texas 77030 —
Clinical Site McAllen Texas 78503 —
Clinical Site San Antonio Texas 78240 —
Clinical Site San Antonio Texas 78251 —
Clinical Site The Woodlands Texas 77384 —
Clinical Site Willow Park Texas 76807 —
Clinical Site Salt Lake City Utah 84107 —
Clinical Site Norfolk Virginia 23502 —
Clinical Site Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03834753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03834753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →